RxNorm Semantic Concepts Index - 160
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "160".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1600127 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600127 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600127 | camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600129 | lidocaine hydrochloride 37.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1600130 | lidocaine 3.75 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600130 | lidocaine 3.75 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600130 | lidocaine 3.75 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600135 | plutonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600136 | dimetridazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600137 | Cucumis sativus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600138 | Daucus carota subsp. carota whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600139 | Eucalyptus gunnii leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600140 | Juniperus oxycedrus leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600141 | Pinus thunbergii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600142 | ceteareth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600259 | Product containing dasabuvir and ombitasvir and paritaprevir and ritonavir (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1600259 | Product containing dasabuvir and ombitasvir and paritaprevir and ritonavir (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1600259 | Product containing dasabuvir and ombitasvir and paritaprevir and ritonavir (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1600267 | benzoyl peroxide 2.5 % / 2.5 % Topical Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600267 | benzoyl peroxide 2.5 % / 2.5 % Topical Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1600267 | benzoyl peroxide 2.5 % / 2.5 % Topical Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600379 | diclofenac / fluorouracil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1600380 | diclofenac / fluorouracil Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1600381 | diclofenac / fluorouracil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1600382 | fluorouracil 5 % / diclofenac sodium 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600382 | fluorouracil 5 % / diclofenac sodium 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600382 | fluorouracil 5 % / diclofenac sodium 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600382 | fluorouracil 5 % / diclofenac sodium 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600382 | fluorouracil 5 % / diclofenac sodium 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600400 | Vitapirena | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1600401 | camphor 0.048 MG/MG / Eucalyptus oil 0.012 MG/MG / menthol 0.026 MG/MG [Vitapirena] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1600402 | camphor / Eucalyptus oil / menthol Topical Ointment [Vitapirena] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1600403 | Vitapirena Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600404 | Vitapirena (camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % ) Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1600404 | Vitapirena (camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % ) Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600404 | Vitapirena (camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % ) Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600435 | Artemisia princeps whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600436 | paritaprevir dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1600437 | ombitasvir heminonahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1600438 | dasabuvir sodium monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1600438 | dasabuvir sodium monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1600438 | dasabuvir sodium monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1600439 | totarol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1600440 | octanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600441 | lauryl trisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600442 | Pediculus humanus var. capitis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600515 | Uralgic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1600516 | hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG [Uralgic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1600517 | hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Uralgic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1600518 | Uralgic Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600519 | Uralgic Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600520 | URALGIC 0.12 MG / 81.6 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1600520 | URALGIC 0.12 MG / 81.6 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600520 | URALGIC 0.12 MG / 81.6 MG / 10.8 MG / 36.2 MG / 40.8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600595 | Buddleja davidii leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600596 | PEG-12 dimethicone/PPG-20 crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600597 | EContra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1600598 | levonorgestrel 1.5 MG [EContra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600599 | levonorgestrel Oral Tablet [EContra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1600600 | EContra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600601 | EContra Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600602 | EContra EZ Emergency Contraceptive 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600602 | EContra EZ Emergency Contraceptive 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600602 | EContra EZ Emergency Contraceptive 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600611 | capsaicin 0.035 % / lidocaine 0.5 % / menthol 5 % / methyl salicylate 20 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600611 | capsaicin 0.035 % / lidocaine 0.5 % / menthol 5 % / methyl salicylate 20 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600611 | capsaicin 0.035 % / lidocaine 0.5 % / menthol 5 % / methyl salicylate 20 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600688 | Evekeo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1600691 | Evekeo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600692 | Evekeo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600694 | amphetamine sulfate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1600695 | amphetamine sulfate 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600695 | amphetamine sulfate 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600696 | amphetamine sulfate 10 MG [Evekeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600697 | amphetamine Oral Tablet [Evekeo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1600698 | Evekeo 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600698 | Evekeo 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600698 | Evekeo 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600699 | amphetamine sulfate 5 MG [Evekeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600700 | Evekeo 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600700 | Evekeo 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600700 | Evekeo 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600701 | cobicistat / darunavir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1600701 | cobicistat / darunavir Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1600701 | cobicistat / darunavir Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1600702 | cobicistat / darunavir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1600703 | cobicistat / darunavir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1600704 | darunavir 800 MG / cobicistat 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600704 | darunavir 800 MG / cobicistat 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1600704 | darunavir 800 MG / cobicistat 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600704 | darunavir 800 MG / cobicistat 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1600705 | Prezcobix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1600706 | cobicistat 150 MG / darunavir 800 MG [Prezcobix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600707 | cobicistat / darunavir Oral Tablet [Prezcobix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1600708 | Prezcobix Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600709 | Prezcobix Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600710 | Prezcobix 800 MG / 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600710 | Prezcobix 800 MG / 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600710 | Prezcobix 800 MG / 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600711 | Perindopril arginine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1600711 | Perindopril arginine | Designated preferred name (PT) | YES | |
| RxCUI: 1600711 | Perindopril arginine | Full form of descriptor (FN) | YES | |
| RxCUI: 1600712 | perindopril arginine 14 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1600713 | amlodipine / perindopril Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1600713 | amlodipine / perindopril Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600713 | amlodipine / perindopril Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1600713 | amlodipine / perindopril Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1600714 | amlodipine / perindopril Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1600714 | amlodipine / perindopril Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600715 | amlodipine / perindopril Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1600715 | amlodipine / perindopril Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600716 | perindopril arginine 14 MG / amLODIPine 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600716 | perindopril arginine 14 MG / amLODIPine 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600716 | perindopril arginine 14 MG / amLODIPine 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600716 | perindopril arginine 14 MG / amLODIPine 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600716 | perindopril arginine 14 MG / amLODIPine 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600717 | Prestalia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1600718 | amlodipine 10 MG / perindopril arginine 14 MG [Prestalia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600718 | amlodipine 10 MG / perindopril arginine 14 MG [Prestalia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600719 | amlodipine / perindopril Oral Tablet [Prestalia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1600719 | amlodipine / perindopril Oral Tablet [Prestalia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600720 | Prestalia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600721 | Prestalia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600722 | Prestalia 14 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600723 | perindopril arginine 3.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1600724 | perindopril arginine 3.5 MG / amLODIPine 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600724 | perindopril arginine 3.5 MG / amLODIPine 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600724 | perindopril arginine 3.5 MG / amLODIPine 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600724 | perindopril arginine 3.5 MG / amLODIPine 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600724 | perindopril arginine 3.5 MG / amLODIPine 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600725 | amlodipine 2.5 MG / perindopril arginine 3.5 MG [Prestalia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600725 | amlodipine 2.5 MG / perindopril arginine 3.5 MG [Prestalia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600726 | Prestalia 3.5 MG / 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600727 | perindopril arginine 7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1600728 | perindopril arginine 7 MG / amLODIPine 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600728 | perindopril arginine 7 MG / amLODIPine 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600728 | perindopril arginine 7 MG / amLODIPine 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600728 | perindopril arginine 7 MG / amLODIPine 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600728 | perindopril arginine 7 MG / amLODIPine 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600729 | amlodipine 5 MG / perindopril arginine 7 MG [Prestalia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600729 | amlodipine 5 MG / perindopril arginine 7 MG [Prestalia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600730 | Prestalia 7 MG / 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600731 | ACT Advanced Care | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1600732 | cetylpyridinium chloride 0.7 MG/ML [ACT Advanced Care] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1600733 | cetylpyridinium Mouthwash [ACT Advanced Care] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1600734 | ACT Advanced Care Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600735 | ACT Advanced Care Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600736 | ACT Advanced Care Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600737 | ACT Advanced Care 0.07 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600737 | ACT Advanced Care 0.07 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600737 | ACT Advanced Care 0.07 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600737 | ACT Advanced Care 0.07 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1600738 | Isodon rubescens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600739 | Leucas cephalotes whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600740 | Leucoagaricus leucothites whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600741 | Liriope muscari root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600742 | lithospermum officinale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600743 | Maranta arundinacea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1600744 | Ostericum grosseserratum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600745 | Prunus mume whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600746 | Pseudostellaria heterophylla whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600747 | Rubus fruticosus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600748 | Schinus molle fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1600749 | Senna obtusifolia seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600750 | Torilis japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600751 | Anethum graveolens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600773 | carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600773 | carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600773 | carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600773 | carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600774 | Rytary 23.75 MG / 95 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600774 | Rytary 23.75 MG / 95 MG 8HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600774 | Rytary 23.75 MG / 95 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600774 | Rytary 23.75 MG / 95 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600775 | carbidopa 36.25 MG / levodopa 145 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600775 | carbidopa 36.25 MG / levodopa 145 MG 8HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600775 | carbidopa 36.25 MG / levodopa 145 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600775 | carbidopa 36.25 MG / levodopa 145 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600776 | Rytary 36.25 MG /145 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600776 | Rytary 36.25 MG /145 MG 8HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600776 | Rytary 36.25 MG /145 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600776 | Rytary 36.25 MG /145 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600778 | tetrahydrofurfuryl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600779 | sodium carboxymethyl beta-glucan (DS 0.65-0.85) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1600780 | PCxx Neutral Rinse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1600781 | sodium fluoride 20 MG/ML [PCxx Neutral Rinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600782 | sodium fluoride Mouthwash [PCxx Neutral Rinse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1600783 | PCxx Neutral Rinse Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600784 | PCxx Neutral Rinse Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600785 | PCxx Neutral Rinse Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600786 | PCxx Neutral Rinse 2 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600786 | PCxx Neutral Rinse 2 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600786 | PCxx Neutral Rinse 2 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600786 | PCxx Neutral Rinse 2 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600908 | methylphenidate hydrochloride 60 MG [Ritalin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1600909 | Ritalin LA 60 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1600909 | Ritalin LA 60 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600909 | Ritalin LA 60 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600914 | carbidopa 48.75 MG / levodopa 195 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600914 | carbidopa 48.75 MG / levodopa 195 MG 8HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600914 | carbidopa 48.75 MG / levodopa 195 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600914 | carbidopa 48.75 MG / levodopa 195 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600915 | Rytary 48.75 MG / 195 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600915 | Rytary 48.75 MG / 195 MG 8HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600915 | Rytary 48.75 MG / 195 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600915 | Rytary 48.75 MG / 195 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600916 | carbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600916 | carbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1600916 | carbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600916 | carbidopa 61.25 MG / levodopa 245 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600917 | Rytary 61.25 MG / 245 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600917 | Rytary 61.25 MG / 245 MG 8HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1600917 | Rytary 61.25 MG / 245 MG 8HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600917 | Rytary 61.25 MG / 245 MG 8HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600919 | Ivarest Poison Ivy Itch Spray | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1600920 | pramoxine hydrochloride 10 MG/ML / zinc acetate 1.2 MG/ML [Ivarest Poison Ivy Itch Spray] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1600921 | pramoxine / zinc acetate Topical Spray [Ivarest Poison Ivy Itch Spray] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1600922 | Ivarest Poison Ivy Itch Spray Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1600923 | Ivarest Poison Ivy Itch Spray (pramoxine HCl 1 % / zinc acetate 0.12 % ) Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600923 | Ivarest Poison Ivy Itch Spray (pramoxine HCl 1 % / zinc acetate 0.12 % ) Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600923 | Ivarest Poison Ivy Itch Spray (pramoxine HCl 1 % / zinc acetate 0.12 % ) Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1600924 | choline salicylate 16.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1600925 | choline salicylate 650 MG / caffeine 65 MG in 40 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600925 | choline salicylate 650 MG / caffeine 65 MG in 40 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600925 | choline salicylate 650 MG / caffeine 65 MG in 40 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600926 | choline salicylate 21.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1600927 | choline salicylate 870 MG / caffeine 65 MG in 40 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600927 | choline salicylate 870 MG / caffeine 65 MG in 40 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600927 | choline salicylate 870 MG / caffeine 65 MG in 40 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600928 | lactoferrin, bovine | Designated preferred name (PT) | YES | |
| RxCUI: 1600928 | lactoferrin, bovine | Full form of descriptor (FN) | YES | |
| RxCUI: 1600928 | lactoferrin, bovine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1600929 | 4-butylresorcinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600930 | Mpx - Myeloperoxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600930 | Mpx - Myeloperoxidase | Designated preferred name (PT) | NO | |
| RxCUI: 1600930 | Mpx - Myeloperoxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 1600930 | Mpx - Myeloperoxidase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600931 | methyl dihydroabietate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600974 | benzocaine 15 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600974 | benzocaine 15 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600974 | benzocaine 15 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600974 | benzocaine 15 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600976 | menthol 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600976 | menthol 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600976 | menthol 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600977 | N-butylphthalimide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1600978 | soybean oil 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1600979 | soybean oil 2 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1600979 | soybean oil 2 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1600979 | soybean oil 2 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1600986 | Aspi-Cor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1600987 | aspirin 81 MG [Aspi-Cor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1600988 | aspirin Delayed Release Oral Tablet [Aspi-Cor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1600989 | Aspi-Cor Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600990 | Aspi-Cor Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1600991 | Aspi-Cor 81 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600991 | Aspi-Cor 81 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1600991 | Aspi-Cor 81 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1600991 | Aspi-Cor 81 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601 | Bromhexine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1601 | Bromhexine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1601 | Bromhexine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1601085 | olopatadine 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601086 | olopatadine HCl 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601086 | olopatadine HCl 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601086 | olopatadine HCl 0.7 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601086 | olopatadine HCl 0.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601087 | Pazeo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1601088 | olopatadine 7 MG/ML [Pazeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1601089 | olopatadine Ophthalmic Solution [Pazeo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1601090 | Pazeo Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1601091 | Pazeo 0.7 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1601091 | Pazeo 0.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1601091 | Pazeo 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601091 | Pazeo 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601091 | Pazeo 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601095 | capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601095 | capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601095 | capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601096 | capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG [LidoPro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601097 | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601097 | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601097 | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601098 | lidocaine 5 % / menthol 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1601098 | lidocaine 5 % / menthol 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1601098 | lidocaine 5 % / menthol 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601101 | cholecalciferol 5750 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601102 | cholecalciferol 5750 UNT / folic acid 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601102 | cholecalciferol 5750 UNT / folic acid 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601102 | cholecalciferol 5750 UNT / folic acid 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601102 | cholecalciferol 5750 UNT / folic acid 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601103 | Fungi-Gone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1601104 | tolnaftate 10 MG/ML [Fungi-Gone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1601105 | tolnaftate Topical Solution [Fungi-Gone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1601106 | Fungi-Gone Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1601107 | Fungi-Gone 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1601107 | Fungi-Gone 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601107 | Fungi-Gone 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601107 | Fungi-Gone 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1601110 | mecobalamin Lozenge Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1601111 | mecobalamin Oral Lozenge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1601112 | mecobalamin 1 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601112 | mecobalamin 1 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601112 | mecobalamin 1 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601114 | hydroxypropyl gamma-cyclodextrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601231 | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601231 | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding protein | Full form of descriptor (FN) | YES | |
| RxCUI: 1601231 | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601231 | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding protein | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1601231 | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601231 | Antigen of Neisseria meningitidis serogroup B recombinant factor H binding protein | Designated preferred name (PT) | YES | |
| RxCUI: 1601232 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601232 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein | Full form of descriptor (FN) | YES | |
| RxCUI: 1601232 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601232 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1601232 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601232 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial adhesin A protein | Designated preferred name (PT) | YES | |
| RxCUI: 1601233 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial heparin binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601233 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial heparin binding protein | Full form of descriptor (FN) | YES | |
| RxCUI: 1601233 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial heparin binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601233 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial heparin binding protein | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1601233 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial heparin binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601233 | Antigen of Neisseria meningitidis serogroup B recombinant Neisserial heparin binding protein | Designated preferred name (PT) | YES | |
| RxCUI: 1601236 | Neisseria meningitidis group B strain NZ98/254 outer membrane vesicle | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601236 | Neisseria meningitidis group B strain NZ98/254 outer membrane vesicle | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1601372 | naloxegol 25 MG [Movantik] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601373 | movantik 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601373 | movantik 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601373 | movantik 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601373 | movantik 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601374 | palbociclib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601374 | palbociclib | Designated preferred name (PT) | YES | |
| RxCUI: 1601374 | palbociclib | Full form of descriptor (FN) | YES | |
| RxCUI: 1601374 | palbociclib | Designated preferred name (PT) | YES | |
| RxCUI: 1601374 | palbociclib | Full form of descriptor (FN) | YES | |
| RxCUI: 1601376 | palbociclib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601377 | palbociclib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1601377 | palbociclib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1601377 | palbociclib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1601378 | palbociclib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1601379 | palbociclib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1601380 | palbociclib 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601380 | palbociclib 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1601380 | palbociclib 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601380 | palbociclib 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1601381 | Ibrance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1601382 | palbociclib 100 MG [Ibrance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601383 | palbociclib Oral Capsule [Ibrance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1601384 | Ibrance Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1601385 | Ibrance Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1601386 | Ibrance 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601386 | Ibrance 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601386 | Ibrance 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601387 | palbociclib 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601388 | palbociclib 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601388 | palbociclib 125 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1601388 | palbociclib 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601388 | palbociclib 125 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1601389 | palbociclib 125 MG [Ibrance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601390 | Ibrance 125 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601390 | Ibrance 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601390 | Ibrance 125 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601391 | palbociclib 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601392 | palbociclib 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601392 | palbociclib 75 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1601392 | palbociclib 75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601392 | palbociclib 75 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1601393 | palbociclib 75 MG [Ibrance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601394 | Ibrance 75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601394 | Ibrance 75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601394 | Ibrance 75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601397 | meningococcal group B vaccine 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601398 | Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601399 | Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601400 | Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1601401 | meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1601402 | meningococcal group B vaccine (MenB generic for Bexsero) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601402 | meningococcal group B vaccine (MenB generic for Bexsero) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601402 | meningococcal group B vaccine (MenB generic for Bexsero) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601403 | Bexsero | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1601404 | meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML [Bexsero] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601405 | meningococcal group B vaccine Prefilled Syringe [Bexsero] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1601406 | Bexsero Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1601407 | BEXSERO vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601407 | BEXSERO vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601407 | BEXSERO vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601407 | BEXSERO vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601407 | BEXSERO vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601408 | meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1601409 | meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1601546 | Flex24 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1601547 | camphor 0.779 MG/ML [Flex24] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1601548 | camphor Topical Solution [Flex24] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1601549 | Flex24 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1601550 | Flex24 Pain Pen 7.79 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1601550 | Flex24 Pain Pen 7.79 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601550 | Flex24 Pain Pen 7.79 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601550 | Flex24 Pain Pen 7.79 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1601552 | phenazopyridine hydrochloride 97.5 MG [Azo Urinary Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601553 | AZO Urinary Pain Relief 97.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601553 | AZO Urinary Pain Relief 97.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601553 | AZO Urinary Pain Relief 97.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601563 | salicylic acid 0.066 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1601564 | salicylic acid 6.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1601564 | salicylic acid 6.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1601564 | salicylic acid 6.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601569 | oleth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601596 | triisocetyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601597 | polyquaternium-47 (methacrylamidopropyltrimethylammonium chloride-co-methyl acrylate-co-acrylic acid 45:10:45; 1200000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601650 | Atazanavir- and cobicistat-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1601650 | Atazanavir- and cobicistat-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 1601650 | Atazanavir- and cobicistat-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 1601651 | atazanavir / cobicistat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1601652 | atazanavir / cobicistat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1601653 | Product containing atazanavir and cobicistat (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1601653 | Product containing atazanavir and cobicistat (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 1601653 | Product containing atazanavir and cobicistat (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 1601654 | atazanavir 300 MG / cobicistat 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601654 | atazanavir 300 MG / cobicistat 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1601655 | Evotaz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1601656 | atazanavir 300 MG / cobicistat 150 MG [Evotaz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601657 | atazanavir / cobicistat Oral Tablet [Evotaz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1601658 | Evotaz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1601659 | Evotaz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1601660 | EVOTAZ 300 MG / 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601660 | EVOTAZ 300 MG / 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601660 | EVOTAZ 300 MG / 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601667 | silanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601871 | 11-dehydrotetrahydrocorticosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1601871 | 11-dehydrotetrahydrocorticosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1601875 | 3-epi-25-Hydroxyvitamin D2 | Designated preferred name (PT) | NO | |
| RxCUI: 1601875 | 3-epi-25-Hydroxyvitamin D2 | Full form of descriptor (FN) | NO | |
| RxCUI: 1601876 | 3-epi-25-Hydroxyvitamin D3 | Designated preferred name (PT) | NO | |
| RxCUI: 1601876 | 3-epi-25-Hydroxyvitamin D3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1601879 | camphor 5 % / menthol 16 % / methyl salicylate 15 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601879 | camphor 5 % / menthol 16 % / methyl salicylate 15 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1601879 | camphor 5 % / menthol 16 % / methyl salicylate 15 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601879 | camphor 5 % / menthol 16 % / methyl salicylate 15 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1601946 | Anti-Bacillus subtilis IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601946 | Anti-Bacillus subtilis IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1601946 | Anti-Bacillus subtilis IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601946 | Anti-Bacillus subtilis IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1601949 | Yersinia adhesion protein | Designated preferred name (PT) | NO | |
| RxCUI: 1601949 | Yersinia adhesion protein | Full form of descriptor (FN) | NO | |
| RxCUI: 1601978 | Plenamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1601979 | alanine 21.7 MG/ML / arginine 14.7 MG/ML / aspartate 4.34 MG/ML / glutamate 7.49 MG/ML / glycine 10.4 MG/ML / histidine 8.94 MG/ML / isoleucine 7.49 MG/ML / leucine 10.4 MG/ML / lysine 11.8 MG/ML / methionine 7.49 MG/ML / phenylalanine 10.4 MG/ML / proline 8.94 MG/ML / serine 5.92 MG/ML / threonine 7.49 MG/ML / tryptophan 2.5 MG/ML / tyrosine 0.39 MG/ML / valine 9.6 MG/ML [Plenamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1601980 | alanine / arginine / aspartate / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine Injectable Solution [Plenamine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1601981 | Plenamine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1601982 | Plenamine 15 % Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1601982 | Plenamine 15 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601982 | Plenamine 15 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1601983 | nonoxynol-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601984 | polyquaternium-53 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601985 | aromadendrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601986 | Yucca brevifolia root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601986 | Yucca brevifolia root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601987 | Abronia villosa leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601987 | Abronia villosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601988 | Agave americana stem extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1601988 | Agave americana stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601989 | Fouquieria splendens stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601989 | Fouquieria splendens stem extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1601991 | Opuntia cochenillifera flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601992 | cyclohexyl cinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1601993 | PEG-40 hydrogenated lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601994 | 3,7-dimethyl-1-octanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1601995 | esomeprazole magnesium dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1601995 | esomeprazole magnesium dihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 1601995 | esomeprazole magnesium dihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 1601996 | Gossypium herbaceum seed resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1602 | Bisphosphoglycerate synthase | Designated preferred name (PT) | NO | |
| RxCUI: 1602 | Bisphosphoglycerate synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 1602 | Bisphosphoglycerate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602 | Bisphosphoglycerate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602 | Bisphosphoglycerate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602008 | lidocaine 43 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602009 | glycerin / lidocaine Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602010 | glycerin / lidocaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602011 | glycerin / lidocaine Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1602012 | glycerin / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1602013 | lidocaine HCl 5 % / glycerin 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602013 | lidocaine HCl 5 % / glycerin 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602013 | lidocaine HCl 5 % / glycerin 20 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602013 | lidocaine HCl 5 % / glycerin 20 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602014 | Recticare Wipes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1602015 | glycerin 200 MG/ML / lidocaine 43 MG/ML [Recticare Wipes] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602016 | glycerin / lidocaine Medicated Pad [Recticare Wipes] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1602017 | Recticare Wipes Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602018 | Recticare Wipes Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602019 | RectiCare 5 % / 20 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602019 | RectiCare 5 % / 20 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602019 | RectiCare 5 % / 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602019 | RectiCare 5 % / 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602020 | parathyroid hormone 0.025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602021 | parathyroid hormone Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602023 | parathyroid hormone 25 MCG/Dose in 14 Dose Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602023 | parathyroid hormone 25 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602023 | parathyroid hormone 25 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602023 | parathyroid hormone 25 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602024 | Natpara | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1602025 | parathyroid hormone 0.025 MG/ACTUAT [Natpara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602027 | Natpara Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602028 | Natpara 25 MCG/Dose in 14 Dose Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602028 | Natpara 25 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602028 | Natpara 25 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602028 | Natpara 25 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602029 | parathyroid hormone 0.025 MG/ACTUAT Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1602030 | parathyroid hormone 0.025 MG/ACTUAT Cartridge [Natpara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602030 | parathyroid hormone 0.025 MG/ACTUAT Cartridge [Natpara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602030 | parathyroid hormone 0.025 MG/ACTUAT Cartridge [Natpara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602031 | parathyroid hormone 0.05 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602032 | parathyroid hormone 50 MCG/Dose in 14 Dose Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602032 | parathyroid hormone 50 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602032 | parathyroid hormone 50 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602032 | parathyroid hormone 50 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602033 | parathyroid hormone 0.05 MG/ACTUAT [Natpara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602034 | Natpara 50 MCG/Dose in 14 Dose Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602034 | Natpara 50 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602034 | Natpara 50 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602034 | Natpara 50 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602035 | parathyroid hormone 0.05 MG/ACTUAT Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1602036 | parathyroid hormone 0.05 MG/ACTUAT Cartridge [Natpara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602036 | parathyroid hormone 0.05 MG/ACTUAT Cartridge [Natpara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602037 | parathyroid hormone 0.075 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602038 | parathyroid hormone 75 MCG/Dose in 14 Dose Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602038 | parathyroid hormone 75 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602038 | parathyroid hormone 75 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602038 | parathyroid hormone 75 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602039 | parathyroid hormone 0.075 MG/ACTUAT [Natpara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602040 | Natpara 75 MCG/Dose in 14 Dose Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602040 | Natpara 75 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602040 | Natpara 75 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602040 | Natpara 75 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602041 | parathyroid hormone 0.075 MG/ACTUAT Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1602042 | parathyroid hormone 0.075 MG/ACTUAT Cartridge [Natpara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602042 | parathyroid hormone 0.075 MG/ACTUAT Cartridge [Natpara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602043 | parathyroid hormone 0.1 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602044 | parathyroid hormone 100 MCG/Dose in 14 Dose Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602044 | parathyroid hormone 100 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602044 | parathyroid hormone 100 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602044 | parathyroid hormone 100 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602045 | parathyroid hormone 0.1 MG/ACTUAT [Natpara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602046 | Natpara 100 MCG/Dose in 14 Dose Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602046 | Natpara 100 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602046 | Natpara 100 MCG/Dose in 14 Dose Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602046 | Natpara 100 MCG/Dose in 14 Dose Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602047 | parathyroid hormone 0.1 MG/ACTUAT Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1602048 | parathyroid hormone 0.1 MG/ACTUAT Cartridge [Natpara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602048 | parathyroid hormone 0.1 MG/ACTUAT Cartridge [Natpara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602048 | parathyroid hormone 0.1 MG/ACTUAT Cartridge [Natpara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602087 | Interleukin 1 receptor alpha chain | Designated preferred name (PT) | NO | |
| RxCUI: 1602087 | Interleukin 1 receptor alpha chain | Full form of descriptor (FN) | NO | |
| RxCUI: 1602098 | Lipoprotein midband C | Designated preferred name (PT) | NO | |
| RxCUI: 1602098 | Lipoprotein midband C | Full form of descriptor (FN) | NO | |
| RxCUI: 1602099 | LDL4 - Low density lipoprotein subfraction 4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602099 | LDL4 - Low density lipoprotein subfraction 4 | Designated preferred name (PT) | NO | |
| RxCUI: 1602099 | LDL4 - Low density lipoprotein subfraction 4 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602100 | LDL5 - Low density lipoprotein subfraction 5 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602100 | LDL5 - Low density lipoprotein subfraction 5 | Designated preferred name (PT) | NO | |
| RxCUI: 1602100 | LDL5 - Low density lipoprotein subfraction 5 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602101 | LDL6 - Low density lipoprotein subfraction 6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602101 | LDL6 - Low density lipoprotein subfraction 6 | Designated preferred name (PT) | NO | |
| RxCUI: 1602101 | LDL6 - Low density lipoprotein subfraction 6 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602102 | LDL7 - Low density lipoprotein subfraction 7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602102 | LDL7 - Low density lipoprotein subfraction 7 | Designated preferred name (PT) | NO | |
| RxCUI: 1602102 | LDL7 - Low density lipoprotein subfraction 7 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602106 | empagliflozin / linagliptin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602107 | empagliflozin / linagliptin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602108 | empagliflozin / linagliptin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1602109 | empagliflozin 10 MG / linagliptin 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602109 | empagliflozin 10 MG / linagliptin 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602110 | Glyxambi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1602111 | empagliflozin 10 MG / linagliptin 5 MG [Glyxambi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602112 | empagliflozin / linagliptin Oral Tablet [Glyxambi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1602113 | Glyxambi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602114 | Glyxambi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602115 | Glyxambi 10 MG / 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602115 | Glyxambi 10 MG / 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602115 | Glyxambi 10 MG / 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602118 | empagliflozin 25 MG / linagliptin 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602118 | empagliflozin 25 MG / linagliptin 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602119 | empagliflozin 25 MG / linagliptin 5 MG [Glyxambi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602120 | Glyxambi 25 MG / 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602120 | Glyxambi 25 MG / 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602120 | Glyxambi 25 MG / 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602124 | Acid sphingomyelinase | Designated preferred name (PT) | NO | |
| RxCUI: 1602124 | Acid sphingomyelinase | Full form of descriptor (FN) | NO | |
| RxCUI: 1602125 | Anti-Adenovirus IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602125 | Anti-Adenovirus IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602125 | Anti-Adenovirus IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602125 | Anti-Adenovirus IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602127 | Anti-Aspergillus species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602127 | Anti-Aspergillus species IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602127 | Anti-Aspergillus species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602127 | Anti-Aspergillus species IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | British preferred term (PTGB) | NO | |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602130 | Anti-Bordetella pertussis filamentous hemagglutinin IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602131 | Anti-Bordetella pertussis toxin IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602131 | Anti-Bordetella pertussis toxin IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602131 | Anti-Bordetella pertussis toxin IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602131 | Anti-Bordetella pertussis toxin IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602132 | Anti-Borrelia burgdorferi IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602132 | Anti-Borrelia burgdorferi IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602132 | Anti-Borrelia burgdorferi IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602132 | Anti-Borrelia burgdorferi IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602134 | Anti-Brucella species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602134 | Anti-Brucella species IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602134 | Anti-Brucella species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602134 | Anti-Brucella species IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602135 | Anti-Campylobacter fetus subspecies venerealis IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602135 | Anti-Campylobacter fetus subspecies venerealis IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602135 | Anti-Campylobacter fetus subspecies venerealis IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602135 | Anti-Campylobacter fetus subspecies venerealis IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602136 | Anti-Campylobacter species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602136 | Anti-Campylobacter species IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602136 | Anti-Campylobacter species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602136 | Anti-Campylobacter species IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602138 | Anti-Candida species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602138 | Anti-Candida species IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602138 | Anti-Candida species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602138 | Anti-Candida species IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602140 | Anti-Chlamydia species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602140 | Anti-Chlamydia species IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602140 | Anti-Chlamydia species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602140 | Anti-Chlamydia species IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602148 | Anti-Chlamydophila pneumoniae IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602148 | Anti-Chlamydophila pneumoniae IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602148 | Anti-Chlamydophila pneumoniae IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602148 | Anti-Chlamydophila pneumoniae IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602149 | Anti-Chlamydophila psittaci IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602149 | Anti-Chlamydophila psittaci IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602149 | Anti-Chlamydophila psittaci IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602149 | Anti-Chlamydophila psittaci IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602150 | Anti-Clostridium difficile IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602150 | Anti-Clostridium difficile IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602150 | Anti-Clostridium difficile IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602150 | Anti-Clostridium difficile IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602151 | Anti-Coccidioides immitis IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602151 | Anti-Coccidioides immitis IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602151 | Anti-Coccidioides immitis IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602151 | Anti-Coccidioides immitis IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602152 | Anti-Coccidioides species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602152 | Anti-Coccidioides species IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602152 | Anti-Coccidioides species IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602152 | Anti-Coccidioides species IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602153 | Anti-Coxiella burnetii phase 1 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602153 | Anti-Coxiella burnetii phase 1 IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602153 | Anti-Coxiella burnetii phase 1 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602153 | Anti-Coxiella burnetii phase 1 IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602154 | Anti-Coxiella burnetii phase 2 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602154 | Anti-Coxiella burnetii phase 2 IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602154 | Anti-Coxiella burnetii phase 2 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602154 | Anti-Coxiella burnetii phase 2 IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602156 | Anti-Cytomegalovirus IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602156 | Anti-Cytomegalovirus IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602156 | Anti-Cytomegalovirus IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602156 | Anti-Cytomegalovirus IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602158 | Anti-Entamoeba histolytica | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602158 | Anti-Entamoeba histolytica | Designated preferred name (PT) | NO | |
| RxCUI: 1602158 | Anti-Entamoeba histolytica | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602158 | Anti-Entamoeba histolytica | Full form of descriptor (FN) | NO | |
| RxCUI: 1602159 | Anti-Epstein Barr virus capsid IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602159 | Anti-Epstein Barr virus capsid IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602159 | Anti-Epstein Barr virus capsid IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602159 | Anti-Epstein Barr virus capsid IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602161 | dimethicone 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602161 | dimethicone 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602161 | dimethicone 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602162 | aripiprazole Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1602162 | aripiprazole Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602163 | ARIPiprazole 300 MG Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602169 | aripiprazole 200 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1602169 | aripiprazole 200 MG/ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602171 | ARIPiprazole 400 MG in 2 ML Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602177 | Estriol, conjugated | Designated preferred name (PT) | NO | |
| RxCUI: 1602177 | Estriol, conjugated | Full form of descriptor (FN) | NO | |
| RxCUI: 1602179 | Adhesion protein | Designated preferred name (PT) | NO | |
| RxCUI: 1602179 | Adhesion protein | Full form of descriptor (FN) | NO | |
| RxCUI: 1602181 | Free insulin | Designated preferred name (PT) | NO | |
| RxCUI: 1602181 | Free insulin | Full form of descriptor (FN) | NO | |
| RxCUI: 1602182 | Free progesterone | Designated preferred name (PT) | NO | |
| RxCUI: 1602182 | Free progesterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1602184 | Creatine kinase, MiMi fraction | Designated preferred name (PT) | NO | |
| RxCUI: 1602184 | Creatine kinase, MiMi fraction | Full form of descriptor (FN) | NO | |
| RxCUI: 1602184 | Creatine kinase, MiMi fraction | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602186 | Apolipoprotein A-III | Designated preferred name (PT) | NO | |
| RxCUI: 1602186 | Apolipoprotein A-III | Full form of descriptor (FN) | NO | |
| RxCUI: 1602187 | Anti-Anthemis cotula IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1602187 | Anti-Anthemis cotula IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602187 | Anti-Anthemis cotula IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602187 | Anti-Anthemis cotula IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1602188 | Anti-Blastomyces dermatitidis IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602188 | Anti-Blastomyces dermatitidis IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1602188 | Anti-Blastomyces dermatitidis IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602188 | Anti-Blastomyces dermatitidis IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1602189 | Anti-Carya illinoinensis nut IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602189 | Anti-Carya illinoinensis nut IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1602189 | Anti-Carya illinoinensis nut IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602189 | Anti-Carya illinoinensis nut IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1602190 | Anti-Carya illinoinensis tree IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602190 | Anti-Carya illinoinensis tree IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1602190 | Anti-Carya illinoinensis tree IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602190 | Anti-Carya illinoinensis tree IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1602191 | Anti-Carya tomentosa IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602191 | Anti-Carya tomentosa IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1602191 | Anti-Carya tomentosa IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602191 | Anti-Carya tomentosa IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1602196 | HDL cholesterol 2b | Designated preferred name (PT) | NO | |
| RxCUI: 1602196 | HDL cholesterol 2b | Full form of descriptor (FN) | NO | |
| RxCUI: 1602196 | HDL cholesterol 2b | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602198 | HDL cholesterol 3a | Designated preferred name (PT) | NO | |
| RxCUI: 1602198 | HDL cholesterol 3a | Full form of descriptor (FN) | NO | |
| RxCUI: 1602198 | HDL cholesterol 3a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602199 | HDL cholesterol 3b | Designated preferred name (PT) | NO | |
| RxCUI: 1602199 | HDL cholesterol 3b | Full form of descriptor (FN) | NO | |
| RxCUI: 1602199 | HDL cholesterol 3b | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602200 | HDL cholesterol 3c | Designated preferred name (PT) | NO | |
| RxCUI: 1602200 | HDL cholesterol 3c | Full form of descriptor (FN) | NO | |
| RxCUI: 1602200 | HDL cholesterol 3c | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602203 | IDL cholesterol 1 | Designated preferred name (PT) | NO | |
| RxCUI: 1602203 | IDL cholesterol 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602203 | IDL cholesterol 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602207 | IDL cholesterol 2 | Designated preferred name (PT) | NO | |
| RxCUI: 1602207 | IDL cholesterol 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602207 | IDL cholesterol 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602209 | LDL cholesterol pattern A | Designated preferred name (PT) | NO | |
| RxCUI: 1602209 | LDL cholesterol pattern A | Full form of descriptor (FN) | NO | |
| RxCUI: 1602209 | LDL cholesterol pattern A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602212 | LDL cholesterol, acetylated | Designated preferred name (PT) | NO | |
| RxCUI: 1602212 | LDL cholesterol, acetylated | Full form of descriptor (FN) | NO | |
| RxCUI: 1602212 | LDL cholesterol, acetylated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602216 | Cholesterol in VLDL subfraction 3 | Designated preferred name (PT) | NO | |
| RxCUI: 1602216 | Cholesterol in VLDL subfraction 3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602216 | Cholesterol in VLDL subfraction 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602216 | Cholesterol in VLDL subfraction 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602219 | Cholesterol in VLDL, acetylated | Designated preferred name (PT) | NO | |
| RxCUI: 1602219 | Cholesterol in VLDL, acetylated | Full form of descriptor (FN) | NO | |
| RxCUI: 1602219 | Cholesterol in VLDL, acetylated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602219 | Cholesterol in VLDL, acetylated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602226 | Triglyceride in high density lipoprotein subfraction 2 | Designated preferred name (PT) | NO | |
| RxCUI: 1602226 | Triglyceride in high density lipoprotein subfraction 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602227 | Triglyceride in high density lipoprotein subfraction 3 | Designated preferred name (PT) | NO | |
| RxCUI: 1602227 | Triglyceride in high density lipoprotein subfraction 3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602270 | Antigen of Treponema pallidum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602270 | Antigen of Treponema pallidum | Full form of descriptor (FN) | NO | |
| RxCUI: 1602270 | Antigen of Treponema pallidum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602270 | Antigen of Treponema pallidum | Designated preferred name (PT) | NO | |
| RxCUI: 1602273 | TNF binding protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602273 | TNF binding protein | Designated preferred name (PT) | NO | |
| RxCUI: 1602273 | TNF binding protein | Full form of descriptor (FN) | NO | |
| RxCUI: 1602273 | TNF binding protein | British preferred term (PTGB) | NO | |
| RxCUI: 1602274 | Tau protein, phosphorylated 181 | Designated preferred name (PT) | NO | |
| RxCUI: 1602274 | Tau protein, phosphorylated 181 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602275 | Paraoxonase-arylesterase 1 | Designated preferred name (PT) | NO | |
| RxCUI: 1602275 | Paraoxonase-arylesterase 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602278 | Hepcidin 25 peptide | Designated preferred name (PT) | NO | |
| RxCUI: 1602278 | Hepcidin 25 peptide | Full form of descriptor (FN) | NO | |
| RxCUI: 1602280 | Cytolytic protein | Designated preferred name (PT) | NO | |
| RxCUI: 1602280 | Cytolytic protein | Full form of descriptor (FN) | NO | |
| RxCUI: 1602281 | Alpha-1-fetoprotein, L3 | Designated preferred name (PT) | NO | |
| RxCUI: 1602281 | Alpha-1-fetoprotein, L3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602281 | Alpha-1-fetoprotein, L3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602281 | Alpha-1-fetoprotein, L3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602282 | Beta-1 transferrin | Designated preferred name (PT) | NO | |
| RxCUI: 1602282 | Beta-1 transferrin | Full form of descriptor (FN) | NO | |
| RxCUI: 1602283 | saccharin calcium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1602284 | zinc phosphate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1602285 | zinc phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1602334 | Allo-tetrahydrocorticosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1602334 | Allo-tetrahydrocorticosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1602342 | Free haemoglobin | British preferred term (PTGB) | NO | |
| RxCUI: 1602342 | Free haemoglobin | Designated preferred name (PT) | NO | |
| RxCUI: 1602342 | Free haemoglobin | Full form of descriptor (FN) | NO | |
| RxCUI: 1602345 | Matrix metallopeptidase 9 | Designated preferred name (PT) | NO | |
| RxCUI: 1602345 | Matrix metallopeptidase 9 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602346 | Mold specific IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602346 | Mold specific IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1602346 | Mold specific IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1602348 | Free human chorionic gonadotropin, alpha subunit | Designated preferred name (PT) | NO | |
| RxCUI: 1602348 | Free human chorionic gonadotropin, alpha subunit | Full form of descriptor (FN) | NO | |
| RxCUI: 1602350 | CHI3L1 - chitinase-3-like protein 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602350 | CHI3L1 - chitinase-3-like protein 1 | Designated preferred name (PT) | NO | |
| RxCUI: 1602350 | CHI3L1 - chitinase-3-like protein 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 1602354 | sulfacetamide sodium 10 % / sulfur 4.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602354 | sulfacetamide sodium 10 % / sulfur 4.5 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602355 | sulfacetamide sodium 100 MG/ML / sulfur 45 MG/ML [Rosula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602356 | Rosula 10 % / 4.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602356 | Rosula 10 % / 4.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602356 | Rosula 10 % / 4.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602356 | Rosula 10 % / 4.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602356 | Rosula 10 % / 4.5 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602524 | Apo-transcobalamin II | Designated preferred name (PT) | NO | |
| RxCUI: 1602524 | Apo-transcobalamin II | Full form of descriptor (FN) | NO | |
| RxCUI: 1602529 | Bound insulin | Designated preferred name (PT) | NO | |
| RxCUI: 1602529 | Bound insulin | Full form of descriptor (FN) | NO | |
| RxCUI: 1602539 | Free dihydrotestosterone | Designated preferred name (PT) | NO | |
| RxCUI: 1602539 | Free dihydrotestosterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1602539 | Free dihydrotestosterone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602540 | Free cortisone | Designated preferred name (PT) | NO | |
| RxCUI: 1602540 | Free cortisone | Full form of descriptor (FN) | NO | |
| RxCUI: 1602542 | Free gamma-aminobutyrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602542 | Free gamma-aminobutyrate | Designated preferred name (PT) | NO | |
| RxCUI: 1602542 | Free gamma-aminobutyrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1602543 | Free homocysteine | Designated preferred name (PT) | NO | |
| RxCUI: 1602543 | Free homocysteine | Full form of descriptor (FN) | NO | |
| RxCUI: 1602543 | Free homocysteine | Designated preferred name (PT) | NO | |
| RxCUI: 1602543 | Free homocysteine | Full form of descriptor (FN) | NO | |
| RxCUI: 1602545 | Free hydroxylysine | Designated preferred name (PT) | NO | |
| RxCUI: 1602545 | Free hydroxylysine | Full form of descriptor (FN) | NO | |
| RxCUI: 1602551 | Free pyridinoline | Designated preferred name (PT) | NO | |
| RxCUI: 1602551 | Free pyridinoline | Full form of descriptor (FN) | NO | |
| RxCUI: 1602552 | Free retinol | Designated preferred name (PT) | NO | |
| RxCUI: 1602552 | Free retinol | Full form of descriptor (FN) | NO | |
| RxCUI: 1602556 | 1,4-naphthoquinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1602557 | Fatal-Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1602559 | PENTobarbital Injectable Solution [Fatal-Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1602559 | PENTobarbital Injectable Solution [Fatal-Plus] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1602560 | Fatal-Plus Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1602561 | pentobarbital sodium 392 MG/ML Injectable Solution [Fatal-Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602561 | pentobarbital sodium 392 MG/ML Injectable Solution [Fatal-Plus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602561 | pentobarbital sodium 392 MG/ML Injectable Solution [Fatal-Plus] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1602567 | phenyltoloxamine citrate 29 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602568 | acetaminophen 500 MG / phenyltoloxamine citrate 29 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602568 | acetaminophen 500 MG / phenyltoloxamine citrate 29 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1602568 | acetaminophen 500 MG / phenyltoloxamine citrate 29 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602569 | acetaminophen 500 MG / phenyltoloxamine citrate 29 MG [Relagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602570 | Relagesic 500 MG / 29 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602570 | Relagesic 500 MG / 29 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602570 | Relagesic 500 MG / 29 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602570 | Relagesic 500 MG / 29 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602573 | Alpha linolenate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602576 | Arginosuccinate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602576 | Arginosuccinate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602583 | Namzaric | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1602584 | donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG [Namzaric] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602585 | donepezil / memantine Extended Release Oral Capsule [Namzaric] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1602586 | Namzaric Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602587 | Namzaric Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1602588 | Namzaric 14 MG / 10 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602588 | Namzaric 14 MG / 10 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602588 | Namzaric 14 MG / 10 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602589 | donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule [Namzaric] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602593 | donepezil hydrochloride 10 MG / memantine hydrochloride 28 MG [Namzaric] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602594 | Namzaric 28 MG / 10 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602594 | Namzaric 28 MG / 10 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602594 | Namzaric 28 MG / 10 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602595 | donepezil hydrochloride 10 MG / memantine hydrochloride 28 MG Extended Release Oral Capsule [Namzaric] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602597 | ethanol 60 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1602597 | ethanol 60 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1602597 | ethanol 60 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602598 | Retigabine 100 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1602598 | Retigabine 100 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1602603 | aripiprazole Prefilled Syringe [Abilify] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1602603 | aripiprazole Prefilled Syringe [Abilify] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602604 | Abilify Maintena 300 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602605 | aripiprazole 200 MG/ML Prefilled Syringe [Abilify] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1602605 | aripiprazole 200 MG/ML Prefilled Syringe [Abilify] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1602605 | aripiprazole 200 MG/ML Prefilled Syringe [Abilify] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602607 | Abilify Maintena 400 MG Extended Release Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1602654 | testosterone 30 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1602656 | testosterone 30 MG/ACTUAT [Axiron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1602744 | levothyroxine / potassium iodide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1602745 | levothyroxine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602746 | levothyroxine Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1602747 | levothyroxine / potassium iodide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1602748 | levothyroxine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602749 | levothyroxine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1602750 | levothyroxine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602751 | levothyroxine / liothyronine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602751 | levothyroxine / liothyronine Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1602751 | levothyroxine / liothyronine Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1602752 | levothyroxine / liothyronine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602753 | levothyroxine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1602753 | levothyroxine Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1602753 | levothyroxine Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1603290 | guaiFENesin 380 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603290 | guaiFENesin 380 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603290 | guaiFENesin 380 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603294 | dextromethorphan HBr 15 MG / guaiFENesin 380 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603294 | dextromethorphan HBr 15 MG / guaiFENesin 380 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603294 | dextromethorphan HBr 15 MG / guaiFENesin 380 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603296 | lenvatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603296 | lenvatinib | Designated preferred name (PT) | YES | |
| RxCUI: 1603296 | lenvatinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1603296 | lenvatinib | Designated preferred name (PT) | YES | |
| RxCUI: 1603296 | lenvatinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1603297 | barium oxalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603349 | panobinostat lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1603349 | panobinostat lactate | Designated preferred name (PT) | NO | |
| RxCUI: 1603349 | panobinostat lactate | Full form of descriptor (FN) | NO | |
| RxCUI: 1603350 | Panobinostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603350 | Panobinostat | Designated preferred name (PT) | YES | |
| RxCUI: 1603350 | Panobinostat | Full form of descriptor (FN) | YES | |
| RxCUI: 1603350 | Panobinostat | Designated preferred name (PT) | YES | |
| RxCUI: 1603350 | Panobinostat | Full form of descriptor (FN) | YES | |
| RxCUI: 1603351 | panobinostat 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1603352 | panobinostat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1603352 | panobinostat Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1603352 | panobinostat Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1603353 | panobinostat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1603354 | panobinostat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1603355 | panobinostat 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1603355 | panobinostat 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603355 | panobinostat 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603355 | panobinostat 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603355 | panobinostat 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1603356 | Farydak | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1603357 | panobinostat 10 MG [Farydak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1603358 | panobinostat Oral Capsule [Farydak] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1603359 | Farydak Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1603360 | Farydak Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1603361 | FARYDAK 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603361 | FARYDAK 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603361 | FARYDAK 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1603362 | panobinostat 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1603363 | panobinostat 15 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1603363 | panobinostat 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603363 | panobinostat 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603363 | panobinostat 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603363 | panobinostat 15 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1603364 | panobinostat 15 MG [Farydak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1603365 | FARYDAK 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603365 | FARYDAK 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603365 | FARYDAK 15 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1603366 | panobinostat 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1603367 | panobinostat 20 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1603367 | panobinostat 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603367 | panobinostat 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603367 | panobinostat 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603367 | panobinostat 20 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1603368 | panobinostat 20 MG [Farydak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1603369 | FARYDAK 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603369 | FARYDAK 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603369 | FARYDAK 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1603376 | benzocaine / salicylic acid Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1603377 | salicylic acid 550 MG / benzocaine 20 MG per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603377 | salicylic acid 550 MG / benzocaine 20 MG per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603377 | salicylic acid 550 MG / benzocaine 20 MG per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603378 | Salinocaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1603379 | benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG [Salinocaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1603380 | benzocaine / salicylic acid Topical Ointment [Salinocaine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1603381 | Salinocaine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1603382 | Salinocaine (salicylic acid 550 MG / benzocaine 20 MG) per GM Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1603382 | Salinocaine (salicylic acid 550 MG / benzocaine 20 MG) per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603382 | Salinocaine (salicylic acid 550 MG / benzocaine 20 MG) per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603383 | flunixin 1500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1603384 | flunixin 1500 MG Oral Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603385 | flunixin 1500 MG [Flunazine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1603386 | flunixin Oral Paste [Flunazine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1603387 | Flunazine Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603388 | Flunazine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603389 | Flunazine Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603390 | flunixin 1500 MG Oral Paste [Flunazine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603390 | flunixin 1500 MG Oral Paste [Flunazine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1603391 | flunixin 1500 MG [Vetameg] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1603392 | flunixin Oral Paste [Vetameg] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1603393 | Vetameg Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603394 | Vetameg Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603395 | Vetameg Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603396 | flunixin 1500 MG Oral Paste [Vetameg] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1603396 | flunixin 1500 MG Oral Paste [Vetameg] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603462 | Eyes Alive Lubricating | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1603463 | carboxymethylcellulose sodium 5 MG/ML [Eyes Alive Lubricating] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1603464 | carboxymethylcellulose Ophthalmic Solution [Eyes Alive Lubricating] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1603465 | Eyes Alive Lubricating Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603466 | Eyes Alive Lubricating 0.5 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1603466 | Eyes Alive Lubricating 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603466 | Eyes Alive Lubricating 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603466 | Eyes Alive Lubricating 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603469 | benzalkonium chloride 8.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1603470 | benzalkonium chloride 0.89 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603470 | benzalkonium chloride 0.89 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603470 | benzalkonium chloride 0.89 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603472 | davana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603472 | davana whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603474 | ethyl acetoacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603476 | isobutyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603478 | arabian jasmine whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603478 | arabian jasmine whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603481 | opopanax chironium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603485 | estradiol 10 MG/ML / hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603485 | estradiol 10 MG/ML / hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603486 | estradiol 2.5 MG/ML / hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603486 | estradiol 2.5 MG/ML / hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603487 | estradiol 5 MG/ML / hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603487 | estradiol 5 MG/ML / hydroxyprogesterone caproate (USP) 250 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603488 | pentobarbital sodium 390 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603488 | pentobarbital sodium 390 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603489 | pentobarbital sodium 390 MG/ML [Fatal-Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1603489 | pentobarbital sodium 390 MG/ML [Fatal-Plus] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603490 | pentobarbital sodium 390 MG/ML Injectable Solution [Fatal-Plus] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603490 | pentobarbital sodium 390 MG/ML Injectable Solution [Fatal-Plus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1603490 | pentobarbital sodium 390 MG/ML Injectable Solution [Fatal-Plus] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603494 | fentaNYL 0.0375 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1603494 | fentaNYL 0.0375 MG/HR | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603495 | fentaNYL 37.5 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603496 | fentaNYL 0.0375 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603496 | fentaNYL 0.0375 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603497 | fentaNYL 0.0625 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1603497 | fentaNYL 0.0625 MG/HR | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603498 | fentaNYL 62.5 MCG/HR 72 HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603499 | fentaNYL 0.0625 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603499 | fentaNYL 0.0625 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603500 | fentaNYL 0.0875 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1603500 | fentaNYL 0.0875 MG/HR | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603501 | fentaNYL 87.5 MCG/HR 72HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603502 | fentaNYL 0.0875 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603502 | fentaNYL 0.0875 MG/HR Transdermal System | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1603510 | lanolin 0.22 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1603511 | lanolin 22 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603511 | lanolin 22 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603511 | lanolin 22 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603512 | Dermafix Lanolin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1603513 | lanolin 0.22 MG/MG [Dermafix Lanolin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1603514 | lanolin Topical Ointment [Dermafix Lanolin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1603515 | Dermafix Lanolin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603516 | DermaFix 22 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603516 | DermaFix 22 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603516 | DermaFix 22 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603516 | DermaFix 22 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1603521 | 3,3'-diindolylmethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603522 | glabridin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603523 | PEG-60 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603524 | Scotch spearmint oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 160372 | Levomepromazine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 160372 | Levomepromazine maleate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 160372 | Levomepromazine maleate | Full form of descriptor (FN) | NO | |
| RxCUI: 160372 | Levomepromazine maleate | Designated preferred name (PT) | NO | |
| RxCUI: 1603794 | 3-dehydroxy ceramide 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603794 | 3-dehydroxy ceramide 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603829 | camphor 3 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1603829 | camphor 3 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603829 | camphor 3 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603833 | avibactam sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1603833 | avibactam sodium | Designated preferred name (PT) | YES | |
| RxCUI: 1603833 | avibactam sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 1603834 | avibactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603834 | avibactam | Designated preferred name (PT) | YES | |
| RxCUI: 1603834 | avibactam | Full form of descriptor (FN) | YES | |
| RxCUI: 1603837 | avibactam / cefTAZidime Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1603837 | avibactam / cefTAZidime Injectable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603837 | avibactam / cefTAZidime Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1603837 | avibactam / cefTAZidime Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1603839 | avibactam / cefTAZidime | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1603839 | avibactam / cefTAZidime | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603839 | avibactam / cefTAZidime | Designated preferred name (PT) | YES | |
| RxCUI: 1603839 | avibactam / cefTAZidime | Full form of descriptor (FN) | YES | |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603840 | cefTAZidime / avibactam 2.5 GM Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1603841 | Avycaz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1603844 | Avycaz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1603845 | Avycaz 2.5 GM Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1603845 | Avycaz 2.5 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603845 | Avycaz 2.5 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603845 | Avycaz 2.5 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1603845 | Avycaz 2.5 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603849 | American hazelnut oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603849 | American hazelnut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603850 | Dictamnus dasycarpus root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603851 | melamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603852 | laurocapram | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603853 | Cistanche deserticola stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603854 | butyl maleurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603855 | butyloctyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603856 | sodium lauraminopropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603857 | dodecyl propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603858 | isobornyl acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1603859 | N-caproylsphingosine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1603861 | Ashlyna 91 Day, 3 Month Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1603861 | Ashlyna 91 Day, 3 Month Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1603861 | Ashlyna 91 Day, 3 Month Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1603862 | Derma Cidol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1603863 | chloroxylenol 5 MG/ML [Derma Cidol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1603864 | chloroxylenol Medicated Liquid Soap [Derma Cidol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1603865 | Derma Cidol Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1603866 | DERMA CIDOL 2000 0.5 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1603866 | DERMA CIDOL 2000 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603866 | DERMA CIDOL 2000 0.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603866 | DERMA CIDOL 2000 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603868 | menthol 10.4 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1603868 | menthol 10.4 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1603868 | menthol 10.4 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1604323 | benzalkonium Cl 0.89 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604323 | benzalkonium Cl 0.89 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1604323 | benzalkonium Cl 0.89 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604325 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1604327 | Tolazine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1604328 | tolazoline 100 MG/ML [Tolazine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1604329 | tolazoline Injectable Solution [Tolazine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1604330 | Tolazine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1604331 | tolazoline 100 MG/ML Injectable Solution [Tolazine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604331 | tolazoline 100 MG/ML Injectable Solution [Tolazine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604331 | tolazoline 100 MG/ML Injectable Solution [Tolazine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1604332 | Nuvessa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1604333 | metroNIDAZOLE 0.013 MG/MG [Nuvessa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1604333 | metroNIDAZOLE 0.013 MG/MG [Nuvessa] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1604336 | NUVESSA 1.3 % Vaginal Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1604336 | NUVESSA 1.3 % Vaginal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1604336 | NUVESSA 1.3 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604336 | NUVESSA 1.3 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604338 | sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM per 45 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1604338 | sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM per 45 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604338 | sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM per 45 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1604341 | lenvatinib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1604342 | lenvatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1604342 | lenvatinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1604342 | lenvatinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1604343 | lenvatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1604344 | lenvatinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1604345 | lenvatinib 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604345 | lenvatinib 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1604345 | lenvatinib 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604345 | lenvatinib 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604345 | lenvatinib 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1604345 | lenvatinib 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1604346 | Lenvatinib mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604346 | Lenvatinib mesilate | Full form of descriptor (FN) | NO | |
| RxCUI: 1604346 | Lenvatinib mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1604346 | Lenvatinib mesilate | Designated preferred name (PT) | NO | |
| RxCUI: 1604347 | lenvatinib 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1604348 | lenvatinib 4 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604348 | lenvatinib 4 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1604348 | lenvatinib 4 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604348 | lenvatinib 4 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604348 | lenvatinib 4 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1604348 | lenvatinib 4 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1604349 | lenvatinib 14 MG Daily Dose 30 Day Supply Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1604349 | lenvatinib 14 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604349 | lenvatinib 14 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604349 | lenvatinib 14 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604350 | Lenvima 14 MG daily dose 30 Day Supply Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1604350 | Lenvima 14 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604350 | Lenvima 14 MG daily dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604350 | Lenvima 14 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604351 | lenvatinib 24 MG Daily Dose 30 Day Supply Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1604351 | lenvatinib 24 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604351 | lenvatinib 24 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604351 | lenvatinib 24 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604352 | Lenvima 24 MG daily dose 30 Day Supply Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1604352 | Lenvima 24 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604352 | Lenvima 24 MG daily dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604352 | Lenvima 24 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604383 | lenvatinib 10 MG Daily Dose 30 Day Supply Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1604383 | lenvatinib 10 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604383 | lenvatinib 10 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604384 | Lenvima 10 MG daily dose 30 Day Supply Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1604384 | Lenvima 10 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604384 | Lenvima 10 MG daily dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604384 | Lenvima 10 MG daily dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604394 | lenvatinib 20 MG Daily Dose 30 Day Supply Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1604394 | lenvatinib 20 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604394 | lenvatinib 20 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604394 | lenvatinib 20 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604395 | Lenvima 20 MG Daily Dose 30 Day Supply Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1604395 | Lenvima 20 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604395 | Lenvima 20 MG Daily Dose 30 Day Supply Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604395 | Lenvima 20 MG Daily Dose 30 Day Supply Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604538 | insulin glargine 300 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1604539 | insulin glargine 300 UNT/ML in 1.5 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1604539 | insulin glargine 300 UNT/ML in 1.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604539 | insulin glargine 300 UNT/ML in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604540 | Toujeo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1604541 | insulin glargine 300 UNT/ML [Toujeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1604543 | Toujeo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1604544 | Toujeo 300 UNT/ML in 1.5 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1604544 | Toujeo 300 UNT/ML in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604544 | Toujeo 300 UNT/ML in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604544 | Toujeo 300 UNT/ML in 1.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604545 | insulin glargine 300 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1604546 | insulin glargine 300 UNT/ML Pen Injector [Toujeo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1604546 | insulin glargine 300 UNT/ML Pen Injector [Toujeo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1604556 | hypochlorous acid 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1604557 | hypochlorous acid 0.01 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1604557 | hypochlorous acid 0.01 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604557 | hypochlorous acid 0.01 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1604558 | Lacticaseibacillus casei KE-99 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1604564 | folic acid 1.25 MG / Lactobacillus casei KE-99 60 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1604564 | folic acid 1.25 MG / Lactobacillus casei KE-99 60 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1604564 | folic acid 1.25 MG / Lactobacillus casei KE-99 60 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 160460 | betaine citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 160460 | betaine citrate | Designated preferred name (PT) | NO | |
| RxCUI: 160460 | betaine citrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1605 | Bithionol | Designated preferred name (PT) | NO | |
| RxCUI: 1605 | Bithionol | Full form of descriptor (FN) | NO | |
| RxCUI: 1605064 | filgrastim-sndz | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1605065 | filgrastim-sndz 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1605066 | filgrastim-sndz 300 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605066 | filgrastim-sndz 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605066 | filgrastim-sndz 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605067 | Zarxio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1605068 | filgrastim-sndz 0.6 MG/ML [Zarxio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1605069 | filgrastim Prefilled Syringe [Zarxio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1605070 | Zarxio Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605071 | Zarxio 300 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605071 | Zarxio 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605071 | Zarxio 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605071 | Zarxio 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605072 | filgrastim-sndz 0.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605073 | filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605073 | filgrastim-sndz 0.6 MG/ML Prefilled Syringe [Zarxio] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605074 | filgrastim-sndz 480 MCG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605074 | filgrastim-sndz 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605074 | filgrastim-sndz 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605075 | Zarxio 480 MCG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605075 | Zarxio 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605075 | Zarxio 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605075 | Zarxio 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605082 | Coccinella septempunctata preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1605083 | Astragalus exscapus whole flowering-fruiting extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1605084 | magnesium chlorate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1605086 | Juleber 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1605086 | Juleber 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605086 | Juleber 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605087 | ISOtretinoin 30 MG [Zenatane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1605087 | ISOtretinoin 30 MG [Zenatane] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605088 | ZENATANE 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605088 | ZENATANE 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605088 | ZENATANE 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605088 | ZENATANE 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605091 | Larin 24 Fe 1/20 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1605091 | Larin 24 Fe 1/20 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605091 | Larin 24 Fe 1/20 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Designated preferred name (PT) | YES | |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Full form of descriptor (FN) | YES | |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Designated preferred name (PT) | YES | |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605101 | NPH (neutral protamine hagedorn) insulin | Full form of descriptor (FN) | YES | |
| RxCUI: 1605102 | dextromethorphan hydrobromide 0.04 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605103 | dextromethorphan / lidocaine / trolamine salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1605106 | dextromethorphan / lidocaine / trolamine salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1605107 | dextromethorphan HBr 4 % / lidocaine 4 % / trolamine salicylate 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605107 | dextromethorphan HBr 4 % / lidocaine 4 % / trolamine salicylate 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605107 | dextromethorphan HBr 4 % / lidocaine 4 % / trolamine salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605108 | coal tar 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605109 | coal tar 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605109 | coal tar 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605109 | coal tar 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605110 | coal tar 12.5 MG/ML [Psoriasin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605111 | coal tar Topical Cream [Psoriasin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1605112 | Psoriasin 1.25 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605112 | Psoriasin 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605112 | Psoriasin 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605113 | capsaicin 0.000285 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605114 | Sodium chondroitin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1605114 | Sodium chondroitin sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 1605114 | Sodium chondroitin sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 1605114 | Sodium chondroitin sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605116 | glucosamine 0.05 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605117 | capsaicin / chondroitin sulfates / glucosamine / lidocaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1605120 | capsaicin / chondroitin sulfates / glucosamine / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1605122 | chondroitin sulfates 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605123 | capsaicin 0.0285 % / chondroitin sulfates 3 % / glucosamine 5 % / lidocaine 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605123 | capsaicin 0.0285 % / chondroitin sulfates 3 % / glucosamine 5 % / lidocaine 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605123 | capsaicin 0.0285 % / chondroitin sulfates 3 % / glucosamine 5 % / lidocaine 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605171 | darbepoetin alfa 10 MCG in 0.4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605171 | darbepoetin alfa 10 MCG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605171 | darbepoetin alfa 10 MCG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605172 | Aranesp 10 MCG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605172 | Aranesp 10 MCG in 0.4 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605172 | Aranesp 10 MCG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605172 | Aranesp 10 MCG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605173 | darbepoetin alfa 0.025 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605174 | darbepoetin alfa 0.025 MG/ML Prefilled Syringe [Aranesp] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605174 | darbepoetin alfa 0.025 MG/ML Prefilled Syringe [Aranesp] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605175 | Levocrine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1605176 | levothyroxine sodium 0.1 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605177 | levothyroxine Chewable Tablet [Levocrine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1605178 | Levocrine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1605179 | Levocrine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1605180 | Levocrine Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1605181 | LEVOCRINE 0.1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605181 | LEVOCRINE 0.1 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605181 | LEVOCRINE 0.1 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605182 | levothyroxine sodium 0.2 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605183 | LEVOCRINE 0.2 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605183 | LEVOCRINE 0.2 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605183 | LEVOCRINE 0.2 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605184 | levothyroxine sodium 0.3 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605185 | LEVOCRINE 0.3 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605185 | LEVOCRINE 0.3 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605185 | LEVOCRINE 0.3 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605186 | levothyroxine sodium 0.4 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605187 | LEVOCRINE 0.4 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605187 | LEVOCRINE 0.4 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605187 | LEVOCRINE 0.4 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605188 | levothyroxine sodium 0.5 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605189 | LEVOCRINE 0.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605189 | LEVOCRINE 0.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605189 | LEVOCRINE 0.5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605190 | levothyroxine sodium 0.6 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605191 | LEVOCRINE 0.6 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605191 | LEVOCRINE 0.6 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605191 | LEVOCRINE 0.6 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605192 | levothyroxine sodium 0.7 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605193 | LEVOCRINE 0.7 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605193 | LEVOCRINE 0.7 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605193 | LEVOCRINE 0.7 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605194 | levothyroxine sodium 0.8 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605195 | LEVOCRINE 0.8 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605195 | LEVOCRINE 0.8 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605195 | LEVOCRINE 0.8 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605196 | levothyroxine sodium 1 MG [Levocrine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605197 | LEVOCRINE 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605197 | LEVOCRINE 1 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605197 | LEVOCRINE 1 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605200 | steareth-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1605249 | purple pitcher plant whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605249 | purple pitcher plant whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1605252 | levonorgestrel 52 MG, 8 Year Intrauterine System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605252 | levonorgestrel 52 MG, 8 Year Intrauterine System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605252 | levonorgestrel 52 MG, 8 Year Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605253 | Liletta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1605256 | Liletta Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605257 | Liletta 52 MG, 8 Year Intrauterine System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605257 | Liletta 52 MG, 8 Year Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605257 | Liletta 52 MG, 8 Year Intrauterine System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605257 | Liletta 52 MG, 8 Year Intrauterine System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605362 | levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605362 | levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605362 | levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605362 | levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605362 | levETIRAcetam 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605363 | Elepsia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1605364 | levETIRAcetam 1000 MG [Elepsia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1605364 | levETIRAcetam 1000 MG [Elepsia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605365 | levETIRAcetam Extended Release Oral Tablet [Elepsia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1605365 | levETIRAcetam Extended Release Oral Tablet [Elepsia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605366 | Elepsia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605367 | Elepsia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605368 | Elepsia XR 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605368 | Elepsia XR 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605368 | Elepsia XR 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605368 | Elepsia XR 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605368 | Elepsia XR 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605369 | levETIRAcetam 1000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605369 | levETIRAcetam 1000 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1605370 | levetiracetam 1000 MG Extended Release Oral Tablet [Elepsia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605370 | levetiracetam 1000 MG Extended Release Oral Tablet [Elepsia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605370 | levetiracetam 1000 MG Extended Release Oral Tablet [Elepsia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1605371 | levETIRAcetam 1500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1605371 | levETIRAcetam 1500 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605372 | levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605372 | levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605372 | levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605372 | levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605372 | levETIRAcetam 1500 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605373 | levETIRAcetam 1500 MG [Elepsia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1605373 | levETIRAcetam 1500 MG [Elepsia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605374 | Elepsia XR 1500 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605374 | Elepsia XR 1500 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605374 | Elepsia XR 1500 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605374 | Elepsia XR 1500 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605374 | Elepsia XR 1500 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605375 | levETIRAcetam 1500 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605375 | levETIRAcetam 1500 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1605376 | levetiracetam 1500 MG Extended Release Oral Tablet [Elepsia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605376 | levetiracetam 1500 MG Extended Release Oral Tablet [Elepsia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605376 | levetiracetam 1500 MG Extended Release Oral Tablet [Elepsia] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1605377 | cholecalciferol 1333 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605383 | cholecalciferol 400 UNT / Lactobacillus reuteri 100,000,000 UNT in 5 drops Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605383 | cholecalciferol 400 UNT / Lactobacillus reuteri 100,000,000 UNT in 5 drops Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605383 | cholecalciferol 400 UNT / Lactobacillus reuteri 100,000,000 UNT in 5 drops Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 16054 | kinetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1605434 | benzoyl peroxide 70 MG/ML [Benzepro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1605435 | benzoyl peroxide Medicated Liquid Soap [Benzepro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1605436 | Benzepro Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605437 | BenzePro 7 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605437 | BenzePro 7 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605437 | BenzePro 7 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605438 | benzoyl peroxide 60 MG/ML [Benzepro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1605439 | benzoyl peroxide Medicated Pad [Benzepro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1605440 | Benzepro Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605441 | Benzepro 6 % Medicated Towelette | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605441 | Benzepro 6 % Medicated Towelette | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605441 | Benzepro 6 % Medicated Towelette | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605454 | apremilast 28-day starter pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1605454 | apremilast 28-day starter pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605454 | apremilast 28-day starter pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605455 | Otezla 28-Day Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1605455 | Otezla 28-Day Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605455 | Otezla 28-Day Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605690 | Capsicum extract 0.0003 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1605691 | Capsicum extract / lidocaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1605694 | Capsicum extract / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1605695 | Capsicum extract 0.03 % / lidocaine 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1605695 | Capsicum extract 0.03 % / lidocaine 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1605695 | Capsicum extract 0.03 % / lidocaine 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605701 | isostearyl linoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1605702 | adipic acid-diglycol crosspolymer (20000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1605769 | Vetaket | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1605770 | ketamine 100 MG/ML [Vetaket] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1605771 | ketamine Injectable Solution [Vetaket] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1605772 | Vetaket Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1605773 | ketamine 100 MG/ML Injectable Solution [Vetaket] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1605773 | ketamine 100 MG/ML Injectable Solution [Vetaket] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605775 | human colostrum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1605777 | Juniperberry oil | Designated preferred name (PT) | NO | |
| RxCUI: 1605777 | Juniperberry oil | Full form of descriptor (FN) | NO | |
| RxCUI: 1605777 | Juniperberry oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1605844 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605844 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605844 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605844 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1605844 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1605850 | sulfacetamide / sulfur Medicated Pad [Rosula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1605851 | Rosula Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1605852 | Rosula 10 % / 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1605852 | Rosula 10 % / 5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1605852 | Rosula 10 % / 5 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1605853 | Nitrogen mustard derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 1605853 | Nitrogen mustard derivative | Designated preferred name (PT) | NO | |
| RxCUI: 1605853 | Nitrogen mustard derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 1605853 | Nitrogen mustard derivative | Designated preferred name (PT) | NO | |
| RxCUI: 1606016 | gentamicin 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606017 | mometasone 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1606018 | clotrimazole / gentamicin / mometasone Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1606019 | clotrimazole / gentamicin / mometasone Otic Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1606020 | clotrimazole / gentamicin / mometasone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1606021 | gentamicin sulfate 3 MG / mometasone furoate 1 MG / clotrimazole 10 MG per mL Otic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606021 | gentamicin sulfate 3 MG / mometasone furoate 1 MG / clotrimazole 10 MG per mL Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606022 | Motazol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1606023 | clotrimazole 10 MG/ML / gentamicin 3 MG/ML / mometasone 1 MG/ML [Motazol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1606024 | clotrimazole / gentamicin / mometasone Otic Suspension [Motazol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1606025 | Motazol Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1606026 | MotaZol (gentamicin sulfate 3 MG / mometasone furoate monohydrate 1 MG / clotrimazole 10 MG) per GM Otic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1606026 | MotaZol (gentamicin sulfate 3 MG / mometasone furoate monohydrate 1 MG / clotrimazole 10 MG) per GM Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606026 | MotaZol (gentamicin sulfate 3 MG / mometasone furoate monohydrate 1 MG / clotrimazole 10 MG) per GM Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606045 | capsaicin 0.025 % / menthol 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606045 | capsaicin 0.025 % / menthol 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606045 | capsaicin 0.025 % / menthol 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606046 | camphor 11 % / menthol 16 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606046 | camphor 11 % / menthol 16 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606046 | camphor 11 % / menthol 16 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606047 | camphor 5 % / menthol 1.25 % / methyl salicylate 10 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606047 | camphor 5 % / menthol 1.25 % / methyl salicylate 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606047 | camphor 5 % / menthol 1.25 % / methyl salicylate 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606182 | camphor / menthol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1606183 | camphor 5 % / menthol 1.3 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606183 | camphor 5 % / menthol 1.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606183 | camphor 5 % / menthol 1.3 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606183 | camphor 5 % / menthol 1.3 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606187 | menthol 0.5 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1606194 | Oryctolagus cuniculus liver preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606197 | cholesteryl chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606198 | salicylic acid 8.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1606199 | zinc gluconate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1606200 | pyridoxine / salicylic acid / zinc gluconate Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1606201 | pyridoxine / salicylic acid / zinc gluconate Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1606202 | pyridoxine / salicylic acid / zinc gluconate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1606203 | salicylic acid 0.86 % / zinc gluconate 0.5 % / pyridoxine HCl 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606203 | salicylic acid 0.86 % / zinc gluconate 0.5 % / pyridoxine HCl 0.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606203 | salicylic acid 0.86 % / zinc gluconate 0.5 % / pyridoxine HCl 0.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606203 | salicylic acid 0.86 % / zinc gluconate 0.5 % / pyridoxine HCl 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606203 | salicylic acid 0.86 % / zinc gluconate 0.5 % / pyridoxine HCl 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606204 | Keratolux | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1606205 | pyridoxine hydrochloride 5 MG/ML / salicylic acid 8.6 MG/ML / zinc gluconate 5 MG/ML [Keratolux] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1606206 | pyridoxine / salicylic acid / zinc gluconate Medicated Shampoo [Keratolux] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1606207 | Keratolux Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1606208 | Keratolux 0.86 % / 0.5 % / 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606208 | Keratolux 0.86 % / 0.5 % / 0.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606208 | Keratolux 0.86 % / 0.5 % / 0.5 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1606208 | Keratolux 0.86 % / 0.5 % / 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606208 | Keratolux 0.86 % / 0.5 % / 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606210 | Angelica dahurica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606211 | Lepidium sativum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606212 | Stemona tuberosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1606213 | Panax notoginseng whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606214 | dimethicone/bis-isobutyl PPG-20 crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606217 | daclatasvir dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1606217 | daclatasvir dihydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 1606217 | daclatasvir dihydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1606218 | daclatasvir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606218 | daclatasvir | Designated preferred name (PT) | NO | |
| RxCUI: 1606218 | daclatasvir | Full form of descriptor (FN) | NO | |
| RxCUI: 1606218 | daclatasvir | Designated preferred name (PT) | NO | |
| RxCUI: 1606218 | daclatasvir | Full form of descriptor (FN) | NO | |
| RxCUI: 1606220 | Dioscorea oppositifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606221 | Kaempferia galanga whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606274 | dinutuximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1606274 | dinutuximab | Designated preferred name (PT) | YES | |
| RxCUI: 1606274 | dinutuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 1606274 | dinutuximab | Designated preferred name (PT) | YES | |
| RxCUI: 1606274 | dinutuximab | Full form of descriptor (FN) | YES | |
| RxCUI: 1606275 | dinutuximab 3.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606276 | dinutuximab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1606276 | dinutuximab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1606276 | dinutuximab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1606278 | dinutuximab 17.5 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606278 | dinutuximab 17.5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606278 | dinutuximab 17.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606279 | Unituxin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1606280 | dinutuximab 3.5 MG/ML [Unituxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1606282 | Unituxin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1606283 | Unituxin 17.5 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1606283 | Unituxin 17.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606283 | Unituxin 17.5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606283 | Unituxin 17.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606285 | Tolazil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1606286 | tolazoline 100 MG/ML [Tolazil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1606287 | tolazoline Injectable Solution [Tolazil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1606288 | Tolazil Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1606289 | tolazoline 100 MG/ML Injectable Solution [Tolazil] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606289 | tolazoline 100 MG/ML Injectable Solution [Tolazil] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1606305 | vitamin B 12 5000 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606305 | vitamin B 12 5000 MCG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606305 | vitamin B 12 5000 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606305 | vitamin B 12 5000 MCG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606306 | biotin Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1606307 | biotin Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1606308 | biotin 5000 MCG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606308 | biotin 5000 MCG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606308 | biotin 5000 MCG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606330 | Angelica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606331 | Musa x paradisiaca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606332 | Eutrema japonicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606334 | Grindelia squarrosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606336 | asenapine 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606337 | asenapine 2.5 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606337 | asenapine 2.5 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606337 | asenapine 2.5 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606346 | metoprolol tartrate 37.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606347 | metoprolol tartrate 37.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606347 | metoprolol tartrate 37.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606348 | metoprolol tartrate 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606349 | metoprolol tartrate 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606349 | metoprolol tartrate 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606350 | ketoconazole 0.0015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1606351 | hydrocortisone / ketoconazole Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1606352 | hydrocortisone / ketoconazole Otic Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1606353 | hydrocortisone 1.0 % / ketoconazole 0.15 % Otic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606353 | hydrocortisone 1.0 % / ketoconazole 0.15 % Otic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606353 | hydrocortisone 1.0 % / ketoconazole 0.15 % Otic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606468 | Orcytolagus cuniculus hypothalamus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606469 | Oryctolagus cuniculus lung preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606471 | muscone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606472 | orange oil, distilled | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1606477 | Oryctolagus cuniculus thyroid preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606478 | Foeniculum vulgare leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606479 | diphenyl dimethicone (400 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606480 | Laurus nobilis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606480 | Laurus nobilis leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606481 | clioquinol / hydrocortisone Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1606482 | clioquinol / hydrocortisone Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1606483 | hydrocortisone 1 % / clioquinol 1 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606483 | hydrocortisone 1 % / clioquinol 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606483 | hydrocortisone 1 % / clioquinol 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606487 | menthol 1.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606487 | menthol 1.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606487 | menthol 1.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606489 | asenapine 2.5 MG [Saphris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1606490 | Saphris 2.5 MG Sublingual Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1606490 | Saphris 2.5 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606490 | Saphris 2.5 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606490 | Saphris 2.5 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606492 | 2-(bis(2-methylpropyl)phenoxy)-ethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 16067 | (R)-6-Hydroxynicotine oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 16067 | (R)-6-Hydroxynicotine oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 1606850 | guaiFENesin 200 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606850 | guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1606850 | guaiFENesin 200 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606850 | guaiFENesin 200 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606850 | guaiFENesin 200 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1606851 | European rabbit spinal cord preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606851 | European rabbit spinal cord preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606852 | butyl carbamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606853 | polyethylene glycol 9000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1606854 | edelweiss root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606854 | edelweiss root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1606859 | ivacaftor 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606860 | ivacaftor Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1606861 | ivacaftor Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1606862 | ivacaftor 50 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606862 | ivacaftor 50 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606862 | ivacaftor 50 MG Oral Granules | Designated preferred name (PT) | YES | |
| RxCUI: 1606862 | ivacaftor 50 MG Oral Granules | Full form of descriptor (FN) | YES | |
| RxCUI: 1606863 | ivacaftor 50 MG [Kalydeco] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1606864 | ivacaftor Oral Granules [Kalydeco] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1606865 | Kalydeco Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1606866 | kalydeco 50 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1606866 | kalydeco 50 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606866 | kalydeco 50 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606867 | ivacaftor 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1606868 | ivacaftor 75 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606868 | ivacaftor 75 MG Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1606868 | ivacaftor 75 MG Oral Granules | Designated preferred name (PT) | YES | |
| RxCUI: 1606868 | ivacaftor 75 MG Oral Granules | Full form of descriptor (FN) | YES | |
| RxCUI: 1606869 | ivacaftor 75 MG [Kalydeco] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1606870 | kalydeco 75 MG Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1606870 | kalydeco 75 MG Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606870 | kalydeco 75 MG Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606984 | dimethicone 32.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1606985 | dimethicone 3.23 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1606985 | dimethicone 3.23 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1606985 | dimethicone 3.23 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1606988 | lidocaine HCl 4 % / menthol 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1606988 | lidocaine HCl 4 % / menthol 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1606988 | lidocaine HCl 4 % / menthol 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607001 | Niva-Fol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1607004 | Niva-Fol Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607005 | Niva-Fol Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607009 | camphor / menthol / tetracaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1607010 | camphor / menthol / tetracaine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1607011 | camphor / menthol / tetracaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1607012 | camphor 3 % / menthol 1 % / tetracaine HCl 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607012 | camphor 3 % / menthol 1 % / tetracaine HCl 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607012 | camphor 3 % / menthol 1 % / tetracaine HCl 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1607013 | camphor / histamine / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1607014 | camphor / histamine / menthol Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1607015 | camphor / histamine / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1607016 | camphor 4 % / histamine dihydrochloride 0.025 % / menthol 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607016 | camphor 4 % / histamine dihydrochloride 0.025 % / menthol 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607016 | camphor 4 % / histamine dihydrochloride 0.025 % / menthol 10 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1607111 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607111 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607111 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607112 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1607112 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607112 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607112 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 30 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607215 | undecylenic acid 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1607216 | zinc undecylenate 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1607217 | zinc undecylenate 6 % / undecylenic acid 6 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607217 | zinc undecylenate 6 % / undecylenic acid 6 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1607217 | zinc undecylenate 6 % / undecylenic acid 6 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607293 | calcium carbonate 1330 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1607294 | magnesium hydroxide 235 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1607295 | calcium carbonate 1330 MG / magnesium hydroxide 235 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607295 | calcium carbonate 1330 MG / magnesium hydroxide 235 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607295 | calcium carbonate 1330 MG / magnesium hydroxide 235 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607310 | lime oil, distilled | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607310 | lime oil, distilled | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607311 | isoamyl cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607312 | sericin 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607313 | dimethicone crosspolymer (450000 MPA.S at 12% in cyclopentasiloxane) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607314 | Indigofera tinctoria leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607315 | Prunus apetala whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607316 | glyceryl 1-undecylenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607326 | Acacia decurrens flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607327 | butylene glycol behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607328 | ethyl trisiloxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607329 | trimethyl-1,3-pentanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607560 | Novoeight | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1607563 | Novoeight Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607578 | Dyloject | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1607579 | diclofenac sodium 37.5 MG/ML [Dyloject] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1607581 | Dyloject Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1607582 | Dyloject 37.5 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1607582 | Dyloject 37.5 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607582 | Dyloject 37.5 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607582 | Dyloject 37.5 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607617 | desvenlafaxine succinate 25 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607617 | desvenlafaxine succinate 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607617 | desvenlafaxine succinate 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607619 | Pristiq 25 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1607619 | Pristiq 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607619 | Pristiq 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607619 | Pristiq 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607620 | desvenlafaxine succinate 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1607621 | desvenlafaxine succinate 25 MG Extended Release Oral Tablet [Pristiq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1607621 | desvenlafaxine succinate 25 MG Extended Release Oral Tablet [Pristiq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607622 | camphor 11 % / menthol 11 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1607622 | camphor 11 % / menthol 11 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607622 | camphor 11 % / menthol 11 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607629 | amylase 8000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1607630 | protease 8000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1607631 | lipase 4000 UNT / amylase 8000 UNT / protease 8000 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1607631 | lipase 4000 UNT / amylase 8000 UNT / protease 8000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607631 | lipase 4000 UNT / amylase 8000 UNT / protease 8000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607632 | amylase 8000 UNT / lipase 4000 UNT / protease 8000 UNT [Ultresa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1607633 | Ultresa 4000 UNT / 8000 UNT / 8000 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1607633 | Ultresa 4000 UNT / 8000 UNT / 8000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607633 | Ultresa 4000 UNT / 8000 UNT / 8000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1607777 | polyglyceryl-3 polydimethylsiloxyethyl dimethicone (4000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607778 | stearamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607779 | pegoterate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1607781 | deferasirox 180 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1607782 | deferasirox Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1607783 | deferasirox Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1607784 | deferasirox 180 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607784 | deferasirox 180 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1607784 | deferasirox 180 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607784 | deferasirox 180 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1607785 | Jadenu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1607786 | deferasirox 180 MG [Jadenu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1607787 | deferasirox Oral Tablet [Jadenu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1607788 | Jadenu Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607789 | Jadenu Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607790 | Jadenu 180 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1607790 | Jadenu 180 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607790 | Jadenu 180 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607791 | deferasirox 360 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1607792 | deferasirox 360 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607792 | deferasirox 360 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1607792 | deferasirox 360 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607792 | deferasirox 360 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1607793 | deferasirox 360 MG [Jadenu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1607794 | Jadenu 360 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1607794 | Jadenu 360 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607794 | Jadenu 360 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607795 | deferasirox 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1607796 | deferasirox 90 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607796 | deferasirox 90 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1607796 | deferasirox 90 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607796 | deferasirox 90 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1607797 | deferasirox 90 MG [Jadenu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1607798 | Jadenu 90 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1607798 | Jadenu 90 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607798 | Jadenu 90 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607802 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1607803 | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (mIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1607803 | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (mIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607804 | Quadracel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1607807 | Quadracel Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607808 | Quadracel (with mIPV) vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1607808 | Quadracel (with mIPV) vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1607969 | Terra-Vet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1607970 | oxytetracycline 200 MG/ML [Terra-Vet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1607971 | oxytetracycline Injectable Solution [Terra-Vet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1607972 | Terra-Vet Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1607973 | oxytetracycline 200 MG/ML Injectable Solution [Terra-Vet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1607973 | oxytetracycline 200 MG/ML Injectable Solution [Terra-Vet] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1607975 | ferric pyrophosphate citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1607976 | Ferric pyrophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1607976 | Ferric pyrophosphate | Designated preferred name (PT) | YES | |
| RxCUI: 1607976 | Ferric pyrophosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 1607976 | Ferric pyrophosphate | Designated preferred name (PT) | YES | |
| RxCUI: 1607976 | Ferric pyrophosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 1607978 | ferric pyrophosphate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1607981 | Triferic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1607984 | Triferic Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1607986 | ferric pyrophosphate citrate 5.44 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1607988 | ferric pyrophosphate citrate 5.44 MG/ML [Triferic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1607990 | Eth estra-Noreth 0.025-0.8 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Chewable Tablet 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1607990 | Eth estra-Noreth 0.025-0.8 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Chewable Tablet 28 Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1607990 | Eth estra-Noreth 0.025-0.8 MG (24) Chewable Tablet / Ferr fum 75 MG (4) Chewable Tablet 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608012 | capsaicin 0.05 % / lidocaine 2.5 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1608012 | capsaicin 0.05 % / lidocaine 2.5 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608012 | capsaicin 0.05 % / lidocaine 2.5 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608039 | hexamethylene diisocyanate-trimethylol hexyllactone crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608060 | Wal-Dryl PE | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1608061 | diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG [Wal-Dryl PE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1608061 | diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG [Wal-Dryl PE] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1608062 | diphenhydramine / phenylephrine Oral Tablet [Wal-Dryl PE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1608062 | diphenhydramine / phenylephrine Oral Tablet [Wal-Dryl PE] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1608063 | Wal-Dryl PE Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1608064 | Wal-Dryl PE Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1608065 | Wal-Dryl PE Allergy & Sinus 25 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1608065 | Wal-Dryl PE Allergy & Sinus 25 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1608065 | Wal-Dryl PE Allergy & Sinus 25 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608065 | Wal-Dryl PE Allergy & Sinus 25 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1608065 | Wal-Dryl PE Allergy & Sinus 25 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608145 | Aluminium chloride anhydrous | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608145 | Aluminium chloride anhydrous | Full form of descriptor (FN) | NO | |
| RxCUI: 1608145 | Aluminium chloride anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1608145 | Aluminium chloride anhydrous | Designated preferred name (PT) | NO | |
| RxCUI: 1608253 | metroNIDAZOLE 1.3 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1608253 | metroNIDAZOLE 1.3 % Vaginal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1608253 | metroNIDAZOLE 1.3 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608253 | metroNIDAZOLE 1.3 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608253 | metroNIDAZOLE 1.3 % Vaginal Gel | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1608258 | capsaicin 0.0375 % / lidocaine 1 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1608258 | capsaicin 0.0375 % / lidocaine 1 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608258 | capsaicin 0.0375 % / lidocaine 1 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608259 | Silvera | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1608260 | capsaicin 0.000375 MG/MG / lidocaine 0.01 MG/MG / menthol 0.05 MG/MG [Silvera] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1608262 | Silvera Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1608264 | Silvera 0.0375 % / 1 % / 5 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1608264 | Silvera 0.0375 % / 1 % / 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608264 | Silvera 0.0375 % / 1 % / 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608269 | Cholbam | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1608270 | cholic acid 250 MG [Cholbam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1608271 | cholic acid Oral Capsule [Cholbam] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1608272 | Cholbam Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1608273 | Cholbam Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1608274 | Cholbam 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608274 | Cholbam 250 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608274 | Cholbam 250 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1608275 | cholic acid 50 MG [Cholbam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1608276 | Cholbam 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608276 | Cholbam 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608276 | Cholbam 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1608319 | Hibiscus syriacus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1608320 | glycereth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608321 | isavuconazonium sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1608321 | isavuconazonium sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 1608321 | isavuconazonium sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 1608321 | isavuconazonium sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608322 | isavuconazonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1608322 | isavuconazonium | Designated preferred name (PT) | YES | |
| RxCUI: 1608322 | isavuconazonium | Full form of descriptor (FN) | YES | |
| RxCUI: 1608322 | isavuconazonium | Designated preferred name (PT) | YES | |
| RxCUI: 1608322 | isavuconazonium | Full form of descriptor (FN) | YES | |
| RxCUI: 1608323 | isavuconazonium sulfate 186 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1608324 | isavuconazonium Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1608324 | isavuconazonium Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1608324 | isavuconazonium Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1608325 | isavuconazonium Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1608326 | isavuconazonium Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1608327 | isavuconazonium sulfate 186 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608327 | isavuconazonium sulfate 186 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608327 | isavuconazonium sulfate 186 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1608328 | Cresemba | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1608329 | isavuconazonium sulfate 186 MG [Cresemba] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1608330 | isavuconazonium Oral Capsule [Cresemba] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1608331 | Cresemba Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1608332 | Cresemba Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1608333 | Cresemba 186 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608333 | Cresemba 186 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608333 | Cresemba 186 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608333 | Cresemba 186 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1608379 | Ledum palustre whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608391 | manganese pidolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608391 | manganese pidolate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608397 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1608397 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608397 | Lactobacillus rhamnosus GG 10 Billion UNT / inulin 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608469 | menthol 5 % / methyl salicylate 14 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608469 | menthol 5 % / methyl salicylate 14 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1608470 | Pasmol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1608471 | menthol 50 MG/ML / methyl salicylate 140 MG/ML [Pasmol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1608472 | menthol / methyl salicylate Topical Cream [Pasmol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1608473 | Pasmol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1608474 | PASMOL 5 % / 14 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1608474 | PASMOL 5 % / 14 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608474 | PASMOL 5 % / 14 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608476 | glucose 0.45 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1608477 | glucose 15 GM per 33 GM Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1608477 | glucose 15 GM per 33 GM Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608477 | glucose 15 GM per 33 GM Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608477 | glucose 15 GM per 33 GM Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608478 | glucose 0.45 MG/MG [Dex4] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1608479 | Dex4 15 GM per 33 GM Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608479 | Dex4 15 GM per 33 GM Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608479 | Dex4 15 GM per 33 GM Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1608479 | Dex4 15 GM per 33 GM Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608491 | menthol 7 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608491 | menthol 7 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608491 | menthol 7 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1608492 | Rhemu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1608493 | menthol 70 MG/ML / methyl salicylate 100 MG/ML [Rhemu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1608494 | menthol / methyl salicylate Topical Cream [Rhemu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1608495 | Rhemu Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1608496 | Rhemu 7 % / 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1608496 | Rhemu 7 % / 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608496 | Rhemu 7 % / 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608496 | Rhemu 7 % / 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608499 | Xylocaine 2 % with EPINEPHrine 1:100,000 in 1.7 mL Dental Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1608499 | Xylocaine 2 % with EPINEPHrine 1:100,000 in 1.7 mL Dental Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1608499 | Xylocaine 2 % with EPINEPHrine 1:100,000 in 1.7 mL Dental Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608499 | Xylocaine 2 % with EPINEPHrine 1:100,000 in 1.7 mL Dental Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608499 | Xylocaine 2 % with EPINEPHrine 1:100,000 in 1.7 mL Dental Cartridge | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1608500 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Xylocaine with Epinephrine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1608500 | epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Xylocaine with Epinephrine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1608545 | ascorbyl dipalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608546 | Portulaca oreracea seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 160873 | Asparagine synthetase (glutamine-hydrolysing) | Designated preferred name (PT) | NO | |
| RxCUI: 160873 | Asparagine synthetase (glutamine-hydrolysing) | Full form of descriptor (FN) | NO | |
| RxCUI: 160873 | Asparagine synthetase (glutamine-hydrolysing) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608793 | Ethyl-2-cyanoacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608793 | Ethyl-2-cyanoacrylate | Designated preferred name (PT) | NO | |
| RxCUI: 1608793 | Ethyl-2-cyanoacrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1608793 | Ethyl-2-cyanoacrylate | Designated preferred name (PT) | NO | |
| RxCUI: 1608793 | Ethyl-2-cyanoacrylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1608796 | naproxen 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1608797 | naproxen sodium 200 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1608797 | naproxen sodium 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1608797 | naproxen sodium 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608797 | naproxen sodium 200 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1608800 | camphor 2 % / menthol 6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1608800 | camphor 2 % / menthol 6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608800 | camphor 2 % / menthol 6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608801 | camphor 2 % / menthol 6 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1608801 | camphor 2 % / menthol 6 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608801 | camphor 2 % / menthol 6 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1608803 | Bordetella pertussis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1608809 | isavuconazonium Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1608809 | isavuconazonium Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1608809 | isavuconazonium Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1608811 | isavuconazonium sulfate 372 Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608811 | isavuconazonium sulfate 372 Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1608814 | Cresemba Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1608815 | Cresemba 372 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1608815 | Cresemba 372 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1608815 | Cresemba 372 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 160887 | O-Carbamoyl-L-serine deaminase | Designated preferred name (PT) | NO | |
| RxCUI: 160887 | O-Carbamoyl-L-serine deaminase | Full form of descriptor (FN) | NO | |
| RxCUI: 160887 | O-Carbamoyl-L-serine deaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1608966 | Ehrlichia canis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1609065 | Somnapure | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1609066 | diphenhydramine hydrochloride 50 MG [Somnapure] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1609066 | diphenhydramine hydrochloride 50 MG [Somnapure] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1609067 | diphenhydrAMINE Oral Tablet [Somnapure] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1609067 | diphenhydrAMINE Oral Tablet [Somnapure] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1609068 | Somnapure Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1609069 | Somnapure Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1609070 | Somnapure Clinical Strength 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1609070 | Somnapure Clinical Strength 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1609070 | Somnapure Clinical Strength 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609070 | Somnapure Clinical Strength 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1609071 | bis-PEG-PPG-14-14 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1609072 | C11-12 isoparaffin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1609178 | capsaicin 0.00375 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1609179 | capsaicin 0.0375 % / menthol 5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1609179 | capsaicin 0.0375 % / menthol 5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1609179 | capsaicin 0.0375 % / menthol 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609188 | Bassia scoparia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1609189 | Erythroxylum catuaba bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1609190 | gambir leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1609243 | Microbial isolate | Designated preferred name (PT) | NO | |
| RxCUI: 1609243 | Microbial isolate | Full form of descriptor (FN) | NO | |
| RxCUI: 1609380 | Anti-Candida albicans IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609380 | Anti-Candida albicans IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1609380 | Anti-Candida albicans IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609380 | Anti-Candida albicans IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1609496 | Anti-Chlamydia trachomatis C IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609496 | Anti-Chlamydia trachomatis C IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1609496 | Anti-Chlamydia trachomatis C IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609496 | Anti-Chlamydia trachomatis C IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 1609705 | Betula populifolia IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609705 | Betula populifolia IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609705 | Betula populifolia IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1609705 | Betula populifolia IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609705 | Betula populifolia IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609705 | Betula populifolia IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1609867 | Free trypsinogen I | Designated preferred name (PT) | NO | |
| RxCUI: 1609867 | Free trypsinogen I | Full form of descriptor (FN) | NO | |
| RxCUI: 1609901 | Anti-Aflatoxin IgA | Designated preferred name (PT) | NO | |
| RxCUI: 1609901 | Anti-Aflatoxin IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609901 | Anti-Aflatoxin IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1609901 | Anti-Aflatoxin IgA | Full form of descriptor (FN) | NO |